James Smith- pharma
- October 14, 2026
- 2 views
James SmithFDA Approval Pill: Worth a Proven $400M+ Opportunity
FDA approval pill could revolutionize treatment and is projected to generate over $400 million in revenue.
- James Smith
- pharma
- October 9, 2026
- 14 views
Cancer Drug Prices: Clear Path to 70% Savings Ahead
Cancer drug prices could see a significant drop of up to 70% due to government action.
- James Smith
- pharma
- October 7, 2026
- 12 views
Medexus Specialty Drug Launches: A Smart Move for Growth
Medexus specialty drug launches are gaining attention for their potential impact on the market.
- James Smith
- pharma
- October 1, 2026
- 17 views
Sudarshan Chemical’s acquisition is a Smart Move for Growth
Sudarshan Chemical acquisition marks a significant investment in Sudarshan Colorants, enhancing market presence and potential.
- James Smith
- pharma
- September 29, 2026
- 19 views
FDA Approval Bone Drug: Teva’s Proven New Treatment
FDA approval bone drug marks a significant advancement in treatment options.
- James Smith
- pharma
- September 24, 2026
- 25 views
Generic Zofran Launch: A Smart Move for Oncology Care
Generic Zofran launch expands oncology supportive care options in Canada.